MyOme Secures $23M in Series B Funding to Deliver Clinical Whole Genome Insights to Help Families Manage Risk for Inherited Diseases

The oversubscribed series B financing led by Healthcare Venture Partners, added SoftBank Corp. and Natera to existing investors– Sequoia Capital, Foresite Capital, Founders Fund, among others MENLO PARK, Calif., June 21, 2022 /PRNewswire/ -- MyOme, a clinical whole genome platform...

Click to view original post